Citi Pharma Board Approves Demerger Scheme to Vest Real Estate Assets into Wholly Owned SPV for REIT
Citi Pharma Limited (PSX: CPHL) has announced a Board-approved Scheme of Arrangement and Demerger to transfer two prime Lahore properties into a wholly-owned SPV.
Citi Pharma Limited and JS Global Capital Limited Partner to Expand Infrastructure Financing
Citi Pharma Limited signs a Strategic Financial Advisory Agreement with JS Global Capital Limited to optimize investment banking opportunities and future expansion.
Citi Pharma Secures SECP Approval to Launch CITI REIT Management Company for Rs7 Billion Real Estate Portfolio
Citi Pharma Limited receives SECP approval to establish CITI REIT Management Company Limited as a wholly owned subsidiary, planning three Lahore and Islamabad projects with Rs7 billion land contribution.
Citi Pharma Maintains Steady Profit in 1QFY26 Despite Rising Financial Costs
Citi Pharma Limited posted a profit after tax of Rs203.69 million for 1QFY26, marking a 1% rise from last year. While higher finance costs and reduced other income pressured margins, improved gross profit and lower taxation helped sustain steady earnings.
Citi Pharma Issues Clarification on Iraq Expansion Rumors to Counter Misinformation
Citi Pharma has officially denied reports about its alleged Iraq expansion plans, clarifying that no agreements or commitments have been made and urging media platforms to remove inaccurate information.